AMPK–SQSTM1 Feedback Under Metabolic Stress

Metabolic stress forces cancer cells to balance limited nutrients, declining energy production, and increasing reactive oxygen species (ROS). The reference study, published in Autophagy, examines how two stress-response systems—STK11/LKB1–AMPK signaling and KEAP1–NFE2L2/NRF2 antioxidant signaling—communicate rather than operate independently. Its central contribution is the identification of a double-positive feedback loop between AMPK and SQSTM1/p62 that reinforces both pathways.

Study Background and Research Question

Glucose limitation and oxidative damage can create a self-reinforcing metabolic problem. Reduced nutrient flux limits NADPH generation and antioxidant capacity, while ROS can impair mitochondrial respiration and further reduce ATP production. STK11 activates AMPK in response to energy stress, helping cells conserve ATP and preserve metabolic balance. In parallel, NFE2L2/NRF2 induces antioxidant and detoxification programs when released from its repressor KEAP1.

The biological context is particularly relevant to non-small cell lung cancer (NSCLC), where STK11/LKB1 and KEAP1 alterations frequently occur together. Loss of STK11 can weaken AMPK activity, whereas KEAP1 disruption can increase NRF2 activity. The study asks whether these pathways are connected by an adaptive mechanism that allows tumor cells to maintain antioxidant defense despite metabolic stress. The authors address this question in the reference study by analyzing SQSTM1/p62 as a possible integrator of lysosomal, metabolic, and oxidative signals.

Key Innovation from the Reference Study

The key innovation is the demonstration that SQSTM1 is not only an autophagy-associated scaffold or cargo receptor. Under metabolic stress, increased and phosphorylated SQSTM1 simultaneously supports two protective outputs. First, it promotes autophagic degradation of KEAP1, thereby enabling NFE2L2/NRF2-dependent antioxidant transcription. Second, it facilitates formation of the AXIN–STK11–AMPK complex at the lysosomal membrane, promoting AMPK activation.

The relationship is reciprocal. STK11–AMPK activity is also required for the stress-induced increase in SQSTM1 expression and phosphorylation. This creates a double-positive circuit: metabolic stress increases SQSTM1, SQSTM1 activates AMPK and NRF2, and AMPK activity feeds back to sustain SQSTM1. The model therefore explains how a transient nutrient deficit can be converted into a durable adaptive state rather than a short-lived signaling response.

This framework extends the interpretation of STK11–AMPK and KEAP1–NRF2 alterations. Rather than treating the two pathways as separate compensatory systems, the paper places them within a shared lysosomal stress network. That conceptual shift is important for interpreting tumor adaptation, because blocking one arm may leave the other arm reinforced through SQSTM1.

Methods and Experimental Design Insights

The experimental design combines stress induction, pathway perturbation, biochemical analysis, and rescue-style interventions. Low-nutrient or low-glucose conditions were used to model metabolic stress, with nutrient-replete conditions providing the comparison state. The study then examined changes in SQSTM1 abundance and phosphorylation together with AMPK activation, KEAP1 turnover, NRF2 signaling, lysosomal acidification, ROS, and lysosomal calcium handling.

Pharmacological perturbations of lysosomal function, including bafilomycin A1 and concanamycin A, were used to test whether lysosomal acidification and proton handling were upstream of the response. Genetic or pathway-directed experiments assessed the roles of SQSTM1, STK11–AMPK, KEAP1, TFEB/TFE3, and MAP3K7/TAK1. Protein-interaction and phosphorylation analyses were especially important because the proposed mechanism depends on complex formation and site-specific modification, not simply on total protein abundance.

The study also used interventions related to ROS and extracellular proton availability. These experiments helped distinguish nutrient deprivation itself from secondary changes in redox state and pH. The finding that lactic-acid-derived protons abrogated several metabolic-stress effects provided a useful environmental control: a low-glucose condition does not produce a fixed response if extracellular buffering and proton availability differ.

Protocol Parameters

• Metabolic-stress comparison: Use low-nutrient or low-glucose conditions alongside nutrient-replete controls, with matched cell density and sampling windows so that stress responses are not confounded by growth differences.
• Lysosomal perturbation: The paper uses bafilomycin A1 and concanamycin A as lysosomal acidification perturbations. In replication studies, these treatments should be interpreted as pathway probes rather than as selective tests of a single molecular target.
• Core pathway readouts: Measure SQSTM1 abundance and phosphorylation together with AMPK activation, KEAP1 degradation, NRF2 activity, and relevant antioxidant outputs. Total SQSTM1 alone cannot establish the proposed feedback loop.
• Mechanistic controls: Include interventions that test ROS, lysosomal pH, proton availability, and lysosomal calcium release. Rescue or reversal experiments are more informative than one-directional inhibitor studies for separating cause from correlation.
• Site-specific interpretation: Evaluate SQSTM1 phosphorylation at S24 and S226 when testing the AMPK–NRF2 connection, because the study identifies these sites as critical for the dual response.

Core Findings and Why They Matter

Several findings establish the proposed circuit. Metabolic stress increased both SQSTM1 expression and phosphorylation, and SQSTM1 was necessary for activation of AMPK and NRF2. Mechanistically, SQSTM1 promoted KEAP1 removal through autophagy while also supporting lysosomal recruitment of the AXIN–STK11–AMPK signaling complex. These results link autophagic cargo handling to energy sensing and antioxidant transcription within one response network.

The upstream mechanism adds another layer of integration. Reduced glucose metabolism and AMPK-dependent proton reduction caused lysosomal deacidification. This change promoted PPP2/PP2A-dependent dephosphorylation of TFEB and TFE3, transcription factors that increased SQSTM1 expression. In parallel, ROS and pH-dependent lysosomal calcium secretion activated MAP3K7/TAK1, which increased SQSTM1 phosphorylation. Thus, lysosomal pH, calcium, redox state, and energy signaling converge on the same scaffold.

Phosphorylation at SQSTM1 S24 and S226 was particularly important. The study reports that these sites were required for effective activation of AMPK and NRF2, indicating that SQSTM1 function is regulated qualitatively as well as quantitatively. A rise in total p62 may therefore have a different biological meaning from the production of a specifically phosphorylated p62 pool.

The lactic-acid result is also significant. Protons supplied by lactic acid blocked the effects attributed to metabolic stress, suggesting that the extracellular and lysosomal proton environment can reshape the response to nutrient limitation. In tumors, this observation may help explain why apparently similar nutrient conditions generate different signaling outcomes in different microenvironments.

For cancer biology, the findings offer a plausible explanation for why STK11 and KEAP1 alterations can coexist. When AMPK activity is compromised, NRF2 activation through KEAP1 loss may preserve antioxidant defense; when NRF2 signaling is available, it may compensate for some consequences of impaired energy-stress adaptation. The work supports this as a mechanistic model of tumor resilience, but it does not by itself establish that the mutations are selected exclusively through this pathway or that targeting SQSTM1 will be therapeutically effective.

Comparison with Existing Internal Articles

The internal article Double-Positive AMPK–SQSTM1 Feedback Enhances Antioxidant Defense presents the same study at a conceptual level, emphasizing the connection between AMPK, SQSTM1/p62, and NRF2. The reference paper provides the deeper mechanistic basis: it identifies KEAP1 degradation and AXIN–STK11–AMPK complex formation as distinct routes through which SQSTM1 produces dual pathway activation.

A second overview, AMPK–SQSTM1 Feedback in Metabolic Stress, focuses on the lysosomal setting and the reciprocal relationship between AMPK and SQSTM1. The primary study extends that summary by connecting lysosomal deacidification to TFEB/TFE3 regulation and linking ROS- and pH-dependent calcium release to TAK1-mediated SQSTM1 phosphorylation. Together, these resources are useful for orientation, while the cited Autophagy article remains the basis for interpreting the experimental claims.

Limitations and Transferability

The study is mechanistically rich, but several limitations affect transferability. Stress conditions in cultured cells cannot reproduce the spatial gradients of glucose, oxygen, lactate, and acidity found in a tumor. The magnitude and timing of lysosomal deacidification may also depend on cell lineage, basal autophagic flux, mitochondrial state, and the presence of STK11 or KEAP1 alterations.

Because AMPK, ROS, lysosomal pH, calcium, and phosphatase activity are tightly interconnected, pharmacological perturbations may have overlapping effects. Genetic depletion, rescue experiments, and site-specific SQSTM1 mutants strengthen the causal model, but additional validation in genetically defined tumors and in vivo systems would be needed to establish therapeutic relevance. The association with co-occurring NSCLC mutations should therefore be viewed as a biologically supported explanation rather than a clinical biomarker rule.

Finally, the importance of S24 and S226 may not be universal across all stress contexts. Their contribution should be tested in the relevant cellular background rather than assumed from total p62 measurements. These considerations favor pathway-resolved assays that distinguish expression, phosphorylation, localization, and functional output.

Research Support Resources

The reference study supports a practical workflow centered on matched metabolic-stress controls, lysosomal perturbation, site-specific SQSTM1 analysis, and parallel AMPK–NRF2 readouts. Such a design can help researchers determine whether a phenotype reflects energy sensing, antioxidant transcription, lysosomal remodeling, or their feedback relationship.

Why this cross-domain matters, maturity, and limitations

The paper concerns cancer-cell adaptation to metabolic and oxidative stress, whereas TRPV1 tools are used in sensory neuron signaling studies. This is a methodological bridge, not evidence that the AMPK–SQSTM1 circuit regulates TRPV1. For separate pain mechanism research workflows, researchers can use AMG 9810 (SKU B7018), a selective competitive TRPV1 antagonist, in experiments assessing inhibition of capsaicin-induced calcium influx or a CGRP release inhibition assay. The product information should be consulted for solvent handling and storage, and results should not be interpreted as a direct validation of the metabolic-stress mechanism described in the reference paper.